Improving Access to Essential Medicines and Basic Technologies for Non-communicable Diseases


Access to medicines and technologies for non-communicable diseases is poor in low and middle-income countries. Building on the Swiss comparative advantage (broader access engagement as a country with a big pharma sector), the program addresses all components of the comprehensive framework for access to drugs, ranging from research and innovation to dispensing and use. It will also set up a dedicated global collaborative network for advocacy, information and innovation.

Paese/Regione Tema Periodo Budget
Mondo
Sanità
Assistenza sanitaria primaria
Rafforzamento dei sistemi sanitari
01.11.2019 - 31.12.2031
CHF  18’000’000
Direzione/Ufficio responsabile DSC
Credito Cooperazione allo sviluppo
Partner del progetto Partner contrattuale
Instituzione universitaria e di ricerca svizzera
  • Other Swiss academic and research institutions


Budget Fase in corso Budget Svizzera CHF    18’000’000 Budget svizzero attualmente già speso CHF    0
Fasi del progetto Fase 99 01.11.2019 - 31.12.2031   (Fase in corso)